Agenda - Main Conference - Day 2 (Apr 28) | TIDES USA: Oligonucleotide & Peptide Therapeutics

Concurrent Tracks

Showing 1 of 1 Streams

Oligonucleotide Discovery, Preclinical and Clinical

8:25am - 8:30am

Co-Chairs' Remarks

8:30am - 9:00am

Conditionally Activated siRNA: Precision RNA Therapeutics through Cell-specific Activation

9:00am - 9:30am

Advancing ADAR RNA Editing Technology for Broad Applicability in Precision Medicines

9:30am - 10:00am

From Discovery toward the Clinic: Translational Development of an ASO Targeting a Cardiac Myofibroblast-specific LncRNA

Showing 1 of 1 Streams

Oligonucleotide Discovery, Preclinical and Clinical

10:45am - 11:15am

Precision RNA Editing at Scale: Platform Innovations Generating Product Candidates

11:15am - 11:45am

Spatial Structured Oligonucleotides for RNA Therapeutics

11:45am - 12:15pm

Improving the Potency and Specificity of RNAi Therapeutics: Carbocyclic DNA and RNA Modifications

12:15pm - 12:20pm

Transition to Spotlight Presentation Rooms

Concurrent Tracks

Showing 1 of 1 Streams

Oligonucleotide Discovery, Preclinical and Clinical

1:55pm - 2:00pm

Chairwoman's Remarks

2:00pm - 2:30pm

Utilization of Oligonucleotides’ Half-Life to Optimize Dosing Regimen for Desirable Efficacy & Reduced CNS Toxicity

2:30pm - 3:00pm

Investigational RNAi Therapeutics in Development for CNS Diseases

3:00pm - 3:30pm

Cellular Correlates of Oligonucleotide-induced Neurotoxicity

Showing 1 of 1 Streams

Oligonucleotide Discovery, Preclinical and Clinical

4:15pm - 4:45pm

FORCE Platform to Enable Delivery of Oligonucleotides for the Treatment of Neuromuscular Diseases

4:45pm - 5:15pm

Activating Anti-tumor Immunity with RNA/DNA Hybrid Agonists of TLR7/8/9

5:15pm - 5:45pm

Targeting the Lung, One Breath at a Time: The Great Promise of Splisense’s ASO Therapeutic Platform to Tackle a Wide Range of Pulmonary Diseases

Informa helps businesses and professionals in hundreds of ways.